Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Suzanne Cohen (Cambridge, United Kingdom), Suzanne Cohen, Ian Scott, Jayesh Majithiya, Laura Rapley, Benjamin Kemp, Nicholas Bond, Dorothy Sims, Christopher Brightling, Robin Butler, Daniel Higazi, Dominic Corkill, Richard May, Tomas Mustelin, Matthew Sleeman. LATE-BREAKING ABSTRACT: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation. Eur Respir J 2015; 46: Suppl. 59, 292

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: TSLP as a potent activator of Th2 response in obstructive lung diseases Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016 LATE-BREAKING ABSTRACT: The CCR4 Antagonist CCX6239 for the treatment of allergic airways disease Source: Annual Congress 2013 –Treatment of asthma Year: 2013 LATE-BREAKING ABSTRACT: Increased IL-33 expression is related to high levels of TLR-2 and -4 in steroid-free subjects with asthma Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014 LATE-BREAKING ABSTRACT: p-STAT6 and PU.1 are involved in IL-9 production by Th9 cells during allergen-induced late phase airway inflammation in asthma patients Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 LATE-BREAKING ABSTRACT: Morin attenuates ovalbumin-induced airway inflammation by modulating oxidative stress-responsive MAPK signaling Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 LATE-BREAKING ABSTRACT: IL-5-induced airways eosinophilia as a negative regulator of TLR7 expression may impair the interferon response to rhinovirus in allergic airways Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014 LATE-BREAKING ABSTRACT: Surfactant protein D is dysregulated in severe asthma Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 LATE-BREAKING ABSTRACT: Serum IL-13 is a peripheral biomarker for Type 2 asthma Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 LATE-BREAKING ABSTRACT: BAFF: a self-perpetuating mechanism of B cell activation in COPD Source: International Congress 2014 – COPD physiopathology Year: 2014 LATE-BREAKING ABSTRACT: Mast cell markers in adipose tissue, systemic inflammation and asthma Source: International Congress 2015 – Asthma and lung immunology Year: 2015 LATE-BREAKING ABSTRACT: Critical role of proton-sensing OGR1 in dendritic cells in development of asthma Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014 LATE-BREAKING ABSTRACT: Phosphoinositide-dependent protein kinase-1 mediates inhibitory effects on eosinophils. Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014 IL5 and IL13 modulate trans-compartmental activation and migration of eosinophils Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 LATE-BREAKING ABSTRACT: The effect of temperature during sputum processing on inflammatory markers Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 NLRP3 inflammasome is activated via phosphoinositide 3-kinase δ pathway in Aspergillus fumigatus-induced allergic airway inflammation Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 TLR-3 triggered exacerbation of experimental asthma depends on IL-17 producing NK cells Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014 Induced sputum cytokines and chemokines and mechanistic pathways in adult asthma phenotypes Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 LATE-BREAKING ABSTRACT: Azithromycin plays an important role in treating diffuse panbronchiolitis by specific inhibition of CXCL-2/MIP-2 and IL-17A in T cells Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Activation of PI3K-d signaling pathway contributes to the generation of mitochondrial ROS and NLRP3 inflammasome in HDM-inhaled mice Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 LATE-BREAKING ABSTRACT: Interleukin-33 augments rhinovirus-induced type 2 immune responses in people with asthma, but not in healthy donors Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015